RxDoctor Payments Data

Donna Cyrus

Adult Health · Fredericksburg, VANPI 1285004572

Payments from drug & device makers

$722in general payments, 2019–2025

Across 31 payments — averaging $23.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$136
  • Neurocrine Biosciences, Inc.$122
  • Avanir Pharmaceuticals, Inc.$106
  • CMP Pharma, Inc.$58
  • Exact Sciences$57
  • Vifor Pharma, Inc.$39
  • plus $205 from 9 others

What the payments were for

  • Food & beverage$722100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$722 in reported general payments places this provider in the 60th percentile of 368 adult health providers in Virginia.

See all adult health providers in Virginia

Medicare billing

Part B allowed, 2024
$1,556,791
Medicare patients
14
Services billed
1,117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide30$27,885
EliquisApixaban42$26,645
JardianceEmpagliflozin19$16,990
OzempicSemaglutide11$10,450
XareltoRivaroxaban28$9,336
LinzessLinaclotide14$7,752
MyrbetriqMirabegron13$6,033
Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc38$3,812
Lacosamide12$2,890
Lantus SolostarInsulin Glargine,hum.Rec.Anlog45$2,376
Atorvastatin Calcium165$2,219
Levemir FlexpenInsulin Detemir21$1,905
Insulin Lispro Kwikpen U-100Insulin Lispro19$1,723
Potassium Chloride41$1,510
Esomeprazole Magnesium12$1,409

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$15$27,88530 claims
Novo NordiskOzempic$13$10,45011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 368 adult health providers in Virginia.

Other adult health in Fredericksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →